Cite
Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population
MLA
Nurul-Ain Mohd-Tahir, and Shu-Chuen Li. “Budget Impact Analysis of Increasing Prescription of Renin-Angiotensin System Inhibitors Drugs to Standard Anti-Hypertensive Treatments in Patients with Diabetes and Hypertension in a Hypothetical Cohort of Malaysian Population.” PLoS ONE, vol. 14, no. 2, Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c970c8e5672dbe822c3cd7a70ee51192&authtype=sso&custid=ns315887.
APA
Nurul-Ain Mohd-Tahir, & Shu-Chuen Li. (2019). Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population. PLoS ONE, 14(2).
Chicago
Nurul-Ain Mohd-Tahir, and Shu-Chuen Li. 2019. “Budget Impact Analysis of Increasing Prescription of Renin-Angiotensin System Inhibitors Drugs to Standard Anti-Hypertensive Treatments in Patients with Diabetes and Hypertension in a Hypothetical Cohort of Malaysian Population.” PLoS ONE 14 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c970c8e5672dbe822c3cd7a70ee51192&authtype=sso&custid=ns315887.